Login / Signup

Challenges and Future Trends in Atopic Dermatitis.

Julius Garcia GatmaitanJi-Hyun Lee
Published in: International journal of molecular sciences (2023)
Atopic dermatitis represents a complex and multidimensional interaction that represents potential fields of preventive and therapeutic management. In addition to the treatment armamentarium available for atopic dermatitis, novel drugs targeting significant molecular pathways in atopic dermatitis biologics and small molecules are also being developed given the condition's complex pathophysiology. While most of the patients are expecting better efficacy and long-term control, the response to these drugs would still depend on numerous factors such as complex genotype, diverse environmental triggers and microbiome-derived signals, and, most importantly, dynamic immune responses. This review article highlights the challenges and the recently developed pharmacological agents in atopic dermatitis based on the molecular pathogenesis of this condition, creating a specific therapeutic approach toward a more personalized medicine.
Keyphrases
  • atopic dermatitis
  • immune response
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • human health
  • dendritic cells
  • risk assessment
  • drug delivery
  • toll like receptor
  • current status